MedPath

NATCO PHARMA ASIA PTE. LTD.

🇸🇬Singapore
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

18

HSA:18

Drug Approvals

DCLOT 2.5 FILM COATED TABLETS 2.5 MG

Approval Date
Jan 11, 2023
HSA

DCLOT 5 FILM COATED TABLETS 5 MG

Approval Date
Jan 11, 2023
HSA

NATFLU OSELTAMIVIR PHOSPHATE USP CAPSULES 30 MG

Approval Date
Jun 21, 2021
HSA

NATFLU OSELTAMIVIR PHOSPHATE USP CAPSULES 75 MG

Approval Date
Jun 21, 2021
HSA

NATFLU OSELTAMIVIR PHOPHATE USP CAPSULES 45 MG

Approval Date
Jun 21, 2021
HSA

GEFTINAT FILM COATED TABLETS 250 MG

Approval Date
Mar 22, 2021
HSA

ABIRANAT TABLETS 250MG USP

Approval Date
Oct 18, 2019
HSA

NATZO 8 TABLETS 8 mg

Approval Date
Feb 9, 2018
HSA

NATZO 4 TABLETS 4mg

Approval Date
Feb 9, 2018
HSA

VEENAT FILM COATED TABLETS 400 mg

Approval Date
Jul 27, 2017
HSA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.